Rani Therapeutics Holdings, Inc. (RANI) Earnings Per Share (EPS)
Rani Therapeutics Holdings, Inc. (RANI) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2021-12-31 | -$0.43 |
| 2022-12-31 | -$1.28 |
| 2023-12-31 | -$1.33 |
| 2024-12-31 | -$1.05 |
| 2025-12-31 | -$0.45 |
How RANI compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ATRC | AtriCure Inc. | -$0.24 |
| MNOV | MediciNova Inc. | -$0.24 |
| TRVI | Trevi Therapeutics Inc. | -$0.32 |
| AVXL | Anavex Life Sciences Corp. | -$0.54 |
| ALDX | Aldeyra Therapeutics Inc. | -$0.56 |
These are five companies in the same sector as RANI with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Rani Therapeutics Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("RANI")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RANI | $0.79 | -0.36% | 0.28M |
| 3 | ||||
| 4 | ||||
| 5 |